Cas9 immunity creates challenges for CRISPR gene editing therapies

Abstract Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 is a genome-editing technology1,2 that utilizes archaeal and bacterial Cas9 nucleases to introduce double-stranded breaks in DNA at targeted sites. These breaks can be used to remove, replace, or add pieces of DNA. Whil...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Julie M. Crudele, Jeffrey S. Chamberlain
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
Q
Acceso en línea:https://doaj.org/article/e6e102c06f9f4413a3b861226fafa27a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!